PenguinMan/ARXIV huggingface dataset:
Mapping the genealogy of medical device predicates in the United States
Authors: Dhruv B Pai
Journal: PLOS ONE
Accepted: 2021-09-19T00:00:00Z

Background: In the United States, medical devices are regulated and subject to review by the Food and Drug Administration (FDA) before they can be marketed. Low-to-medium risk novel medical devices can be reviewed under the De Novo umbrella before they can proceed to market, and this process can be fairly cumbersome, expensive, and time-consuming. An alternate faster and less-expensive pathway to going to market is the 510(k) pathway. In this approach, if the device can be shown to be substantially equivalent in safety and effectiveness to a pre-existing FDA-approved marketed device (or “predicates”), it can be cleared to market. Due to the possibility of daisy-chaining predicate devices, it can very quickly be difficult to unravel the logic and justification of how a particular medical device’s equivalence was established. From patients’ perspective, this minimizes transparency in the process. From a vendor perspective, it can be difficult to determine the right predicate that applies to their device. Methods: We map the connectivity of various predicates in the medical device field by applying text mining and natural language processing (NLP) techniques on data publicly made available by the FDA 78000 device summaries were scraped from the US FDA 510(k) database, and a total of 2,721 devices cleared by the 510(k) regulatory pathway in 2020 were used as a specific case study to map the genealogy of medical devices cleared by the FDA. Cosine similarity was used to gauge the degree of substantial equivalence between two medical devices by evaluating their device descriptions and indications for use. Recalls and complaints for predicate devices were extracted from the FDA’s Total Product Life Cycle database using html scraping and web page optical character recognition to determine the similarity between class 1 recalled devices (the most severe form of device recall) and other substantially equivalent devices. A specific product code was used to illustrate the mapping of the genealogy from a De Novo device. Results and discussion: The ancestral tree for the medical devices cleared in 2020 is vast and sparse, with a large number of devices having only 1–2 predicates. Evaluation of substantial equivalence data from 2003–2020 shows that the standard for substantial equivalence has not changed significantly. Studying the recalls and complaints, shows that the insulin infusion pump had the highest number of complaints, yet none of the recalled devices bore significant degree of text similarity to currently marketed devices. The mapping from the De Novo device case study was used to develop an ancestry map from the recalled predicate (recalled due to design flaws) to current substantially equivalent products in the market. Conclusions: Besides enabling a better understanding of the risks and benefits of the 510(k) process, mapping of connectivity of various predicates could help increase consumer confidence in the medical devices that are currently in the marketplace.
Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson’s disease
Authors: Soutarou Taguchi, Hirofumi Koide, Hiroko Oiwa, Miku Hayashi, Kazuhiro Ogawa, Chihiro Ito, Koji Nakashima, Tomoko Yuasa, Akihiro Yasumoto, Hiroaki Ando, Akifumi Fujikake, Takaaki Fukuoka, Keisuke Tokui, Masayuki Izumi, Yuka Tsunoda, Yuichi Kawagashira, Yohei Okada, Jun-ichi Niwa, Manabu Doyu
Journal: PLOS ONE
Accepted: 2021-07-14T00:00:00Z

Objective: To clarify whether antiparkinsonian drugs contribute to nocturnal sleep disturbances in patients with Parkinson’s disease (PD). Background: Although the major antiparkinsonian drugs L-dopa and dopamine agonists (DAs) have been found to affect sleep, little is known about the effects of specific drugs on sleep in PD patients. Methods: The study participants consisted of 112 PD patients (median age 72.5 years [inter-quartile range: IQR 65–79]; mean disease duration 8.44 years [standard deviation: 7.33]; median Hoehn and Yahr stage 3 [IQR 2–3.75]) taking one of three types of non-ergot extended-release DAs (rotigotine 32; pramipexole 44; ropinirole 36) with or without L-dopa (median daily total dosage of antiparkinsonian drugs 525.5 mg [IQR 376.25–658] levodopa equivalent dose [LED]). Participants were assessed using the PD Sleep Scale-2 (PDSS-2). Results: For the whole PD patient cohort, the PDSS-2 sleep disturbance domain score and the scores for item 1 assessing sleep quality and item 8 assessing nocturia were positively correlated with daily total dosage of antiparkinsonian drugs and dosage of L-dopa, but not with the dosage of DAs. Sub-analysis according to DA treatment revealed that DA dosage was not correlated with item 1 or 8 score in any of the subgroups. The LED ratio of rotigotine to the total dosage of antiparkinsonian drugs was inversely correlated with the item 1 score. Conclusions: These data suggest that antiparkinsonian drugs, in particular L-dopa, adversely affect nocturnal sleep in PD patients, especially in terms of sleep quality and nocturia. Thus, adjusting both the total dosage of antiparkinsonian drugs and the dose-ratio of L-dopa might be key actions for alleviating poor sleep quality in patients with PD. Among DAs, we found a clear positive correlation between the dose-ratio of rotigotine and sleep quality. Thus, partial L-dopa replacement with rotigotine could improve sleep quality in patients with PD.
Classification of masked image data
Authors: Kamila Lis, Mateusz Koryciński, Konrad A Ciecierski
Journal: PLOS ONE
Accepted: 2021-06-21T00:00:00Z


Data classification is one of the most commonly used applications of machine learning. The are many developed algorithms that can work in various environments and for different data distributions that perform this task with excellence. Classification algorithms, just like other machine learning algorithms have one thing in common: in order to operate on data, they must see the data. In the present world, where concerns about privacy, GDPR (General Data Protection Regulation), business confidentiality and security are growing bigger and bigger; this requirement to work directly on the original data might become, in some situations, a burden. In this paper, an approach to the classification of images that cannot be directly accessed during training has been made. It has been shown that one can train a deep neural network to create such a representation of the original data that i) without additional information, the original data cannot be restored, and ii) that this representation—called a masked form—can still be used for classification purposes. Moreover, it has been shown that classification of the masked data can be done using both classical and neural network-based classifiers.
STEAM-DWI as a robust alternative to EPI-DWI: Evaluation in pediatric brain MRI
Authors: Daniel Gräfe, Anne Päts, Andreas Merkenschlager, Christian Roth, Franz Wolfgang Hirsch, Jens Frahm, Dirk Voit
Journal: PLOS ONE
Accepted: 2022-05-02T00:00:00Z

Purpose: Diffusion-weighted imaging (DWI) is an essential element of almost every brain MRI examination. The most widely applied DWI technique, a single-shot echo-planar imaging DWI (EPI-DWI) sequence, suffers from a high sensitivity to magnetic field inhomogeneities. As an alternative, a single-shot stimulated echo acquisition mode diffusion-weighted MRI (STEAM-DWI) has recently been re-introduced after it became significantly faster. The aim of the study was to investigate the applicability of STEAM-DWI as a substitute to EPI-DWI in a daily routine of pediatric radiology. Methods: Retrospectively, brain MRI examinations of 208 children with both EPI-DWI and STEAM-DWI were assessed. Visual resolution and diagnostic confidence were evaluated, the extent of susceptibility artifacts was quantified, and contrast-to-noise ratio was calculated in case of diffusion restriction. Furthermore, the correlation of apparent diffusion coefficient values between STEAM-DWI and EPI-DWI was tested. Results: STEAM-DWI was inferior to EPI-DWI in visual resolution but with higher diagnostic confidence and lower artifact size. The apparent diffusion coefficient values of both sequences demonstrated excellent correlation. The contrast-to-noise ratio of STEAM-DWI was only half of that of EPI-DWI (58% resp. 112%). Conclusion: STEAM-DWI is a robust alternative to EPI-DWI when increased susceptibility artifacts are to be expected. Drawbacks are a lower contrast-to-noise ratio and poorer visual resolution.
Multicenter survey on implantable collamer lens dislocation
Authors: Takashi Kojima, Yoshihiro Kitazawa, Tomoaki Nakamura, Kazutaka Kamiya, Kazuo Ichikawa, Akihito Igarashi, Kimiya Shimizu
Journal: PLOS ONE
Accepted: 2022-01-31T00:00:00Z


This study aimed to investigate the incidence, patient background, and postoperative prognosis of implantable collamer lens (ICL) dislocation. We retrospectively reviewed all cases of ICL dislocation at four major refractive surgery centers in Japan until December 2019. The incidence, patient background, cause of dislocation, complications of repositioning surgery, and postoperative visual function were investigated. Seven ICL dislocations [0.072% of total ICL-implanted eyes (9775 eyes)] occurred at an average of 28.6 months (11–82 months) postoperatively. All patients were male. Five eyes were injured during sports activities, one due to a fall from a bicycle, and another due to ocular blunt trauma caused by a mortuary tablet. Two patients had re-dislocation in the same eye. Retinal detachment occurred after repositioning surgery in one patient, and scleral buckling surgery was performed without ICL removal. ICL dislocation is a rare complication of ICL surgery; repositioning surgery is effective, but retinal complications may occur.
Underwater acoustic target recognition method based on a joint neural network
Authors: Xing Cheng Han, Chenxi Ren, Liming Wang, Yunjiao Bai
Journal: PLOS ONE
Accepted: 2022-03-20T00:00:00Z


To improve the recognition accuracy of underwater acoustic targets by artificial neural network, this study presents a new recognition method that integrates a one-dimensional convolutional neural network and a long short-term memory network. This new network framework is constructed and applied to underwater acoustic target recognition for the first time. Ship acoustic data are used as input to evaluate the network performance. A visual analysis of the recognition results is performed. The results show that this method can realize the recognition and classification of underwater acoustic targets. Compared with a single neural network, the relevant indices, such as the recognition accuracy of the joint network are considerably higher. This provides a new direction for the application of deep learning in the field of underwater acoustic target recognition.
Convergent validity of the Autism Spectrum Disorder Mealtime Behavior Questionnaire (ASD-MBQ) for children with autism spectrum disorder
Authors: Kazuyo Nakaoka, Hiroyuki Tanba, Takuma Yuri, Kiyomi Tateyama, Shigeki Kurasawa
Journal: PLOS ONE
Accepted: 2022-04-04T00:00:00Z


There was a growing interest in difficulties with eating as one of the most problematic symptoms in children with autism spectrum disorder (ASD). The purpose of this study is to examine the convergent validity of the Autism Spectrum Disorder Mealtime Behavior Questionnaire (ASD-MBQ) with the Asahide’s test for social adjustment skills, the Japanese version of the short version of the sensory profile questionnaire, the Japanese version of the Social Communication Questionnaire, and the Parenting Strain Index in Japanese children with ASD. The final sample contained 294 children who were diagnosed as the ASD based on the DSM-5 criteria, the mean age of children was 10 ± 4 years (range: 3–18 years). The ASD-MBQ is a questionnaire that comprised of 42 items that are classified into five subdomains: selective eating, clumsiness/manners, interest in/concentration on eating, oral-motor function, and overeating. Spearman’s rank correlation coefficient revealed that the ASD-MBQ showed the moderate to high correlation coefficient with all four external criteria. Our results in this study supported the sufficient convergent validity in the ASD-MBQ. Therefore, the ASD-MBQ could be a useful tool for research and practice in a wide range of children with ASD aged 3 to 18.
Features of non-traumatic spinal cord infarction on MRI: Changes over time
Authors: Bo Ra Kim, Kyung Seok Park, Hyo Jin Kim, Jun Yup Kim, Bo Ram Kim, Eugene Lee, Joon Woo Lee
Journal: PLOS ONE
Accepted: 2022-09-02T00:00:00Z

Background and purpose: Spinal cord infarction (SCI) is difficult to diagnosis using MRI findings. We aimed to suggest the optimal timing of MRI studies for diagnosing SCI. Materials and methods: This retrospective study was approved by our institutional review board. The requirement for informed consent was waived. MRI scans of SCI patients diagnosed between January 2015 and August 2019 were enrolled in the SCI group and subdivided according to the interval between symptom onset and time of MRI scan (A, within 6 h; B, 6–12 hours; C, 12–24 hours; D, 24–72 hours; E, 3–7 days). Three radiologists analyzed the T2WI scans and evaluated the confidence level of diagnosing SCI using a five-point Likert scale: 1, certainly not; 2, probably not; 3, equivocal; 4, probably yes; 5, certainly yes. Scores of 4 and 5 were defined as “T2WI-positive SCI” and scores of 1–3 were defined as “T2WI-negative SCI”. Results: The SCI group included 58 MRI scans of 34 patients (mean age, 60.6 ± 14.0 years; 18 women). The T2WI positivity rate was 72.4% (42/58). In contrast to the other subgroups, subgroup A included fewer cases of T2WI-positive SCI (1/4, 25%) than T2WI-negative SCI. A confidence score of 5 was the most common in subgroup D (4/27, 14.8%). Among the 12 patients who underwent MRI studies more than twice, confidence scores increased with time. Conclusion: In patients with suspected SCI showing equivocal initial MRI findings, follow-up MRI studies are helpful, especially when performed between 24 and 72 hours after symptom onset.
The Winnipeg Intraspinal Pressure Monitoring Study (WISP): A protocol for validation of fiberoptic pressure monitoring for acute traumatic spinal cord injury
Authors: Perry Dhaliwal, Marshall Wilkinson, Frederick A Zeiler
Journal: PLOS ONE
Accepted: 2021-12-21T00:00:00Z

Background: Research efforts have been focused on limiting secondary injury after traumatic spinal cord injury by performing spinal decompression and early optimization of spinal cord perfusion. The Winnipeg Intraspinal Pressure Monitoring Study (WISP) was designed to validate the technique of intraspinal pressure monitoring at the site of injury using a fiberoptic pressure monitor placed at the site of injury. Objectives: To describe the design of the WISP study. Study design: Descriptive. Methods: We explain the current limitations in the available scientific literature around the topic of blood pressure management for acute traumatic spinal cord injury and rational for the WISP study. Then, we describe the design of WISP including the patient selection criteria, study interventions, follow up schedules and outcome measurements. A multitude of future research avenues are also discussed. Results: The WISP study is a single center pilot study designed to validate the technique of intraspinal pressure monitoring following acute traumatic spinal cord injury. The study involves the measurement of intraspinal pressure from within the subarachnoid space at the site of injury to derive a number of physiological parameters including spinal cord perfusion pressure, spinal cord blood volume, measures of spinal cord compliance and vascular reactivity indices. Twenty eligible patients will be recruited and followed for a period of 12 months with visits scheduled for the first 5 days and 1, 3, 6, and 12 months following surgical intervention. Conclusions: The WISP study will provide the first attempt in North America at validation of intraspinal pressure monitoring with a fiberoptic pressure monitor at the site of injury. Successful validation will lead to future studies to define optimal spinal cord perfusion pressure, relationships of neural injury biomarkers and outcomes as well as epigenetic studies. Trial registration: This study has been registered at clinicaltrials.gov (registration# NCT04550117).
Good recovery of immunization stress-related responses presenting as a cluster of stroke-like events following CoronaVac and ChAdOx1 vaccinations
Authors: Metha Apiwattanakul, Narupat Suanprasert, Arada Rojana-Udomsart, Thanes Termglinchan, Chaichana Sinthuwong, Tasanee Tantirittisak, Suchat Hanchaiphiboolkul, Pantep Angchaisuksiri, Suphot Srimahachota, Jurai Wongsawat, Somjit Stiudomkajorn, Sasisopin Kiertiburanakul, Chonnamet Techasaensiri, Wannada Laisuan, Weerawat Manosuthi, Pawinee Doungngern, Wereyarmarst Jaroenkunathum, Teeranart Jivapaisarnpong, Apinya Panjangampatthana, Jirapa Chimmanee, Kulkanya Chokephaibulkit
Journal: PLOS ONE
Accepted: 2022-08-05T00:00:00Z

Background: Immunization stress-related responses presenting as stroke-like symptoms could develop following COVID-19 vaccination. Therefore, this study aimed to describe the clinical characteristics of immunization stress-related responses causing stroke-like events following COVID-19 vaccination in Thailand. Methods: We conducted a retrospective study of the secondary data of reported adverse events after COVID-19 immunization that presented with neurologic manifestations. Between March 1 and July 31, 2021, we collected and analyzed the medical records of 221 patients diagnosed with stroke-like symptoms following immunization. Two majority types of vaccines were used at the beginning of the vaccination campaign, including CoronaVac (Sinovac) or ChAdOx1 (AstraZeneca). Demographic and medical data included sex, age, vaccine type, sequence dose, time to event, laboratory data, and recovery status as defined by the modified Rankin score. The affected side was evaluated for associations with the injection site. Results: Overall, 221 patients were diagnosed with immunization stress-related responses (stroke-like symptoms) following CoronaVac (Sinovac) or ChAdOx1 (AstraZeneca) vaccinations. Most patients (83.7%) were women. The median (interquartile range) age of onset was 34 (28–42) years in patients receiving CoronaVac and 46 (33.5–60) years in those receiving ChAdOx1. The median interval between vaccination and symptom onset for each vaccine type was 60 (16–960) min and 30 (8.8–750) min, respectively. Sensory symptoms were the most common symptomology. Most patients (68.9%) developed symptoms on the left side of the body; 99.5% of the patients receiving CoronaVac and 100% of those receiving ChAdOx1 had a good outcome (modified Rankin scores ≤2, indicating slight or no disability). Conclusions: Immunization stress-related responses presenting as stroke-like symptoms can develop after COVID-19 vaccination. Symptoms more likely to occur on the injection side are transient (i.e., without permanent pathological deficits). Public education and preparedness are important for administering successful COVID-19 vaccination programs.
Effect of different electrostimulation currents on female urinary incontinence: A protocol of a randomized controlled trial
Authors: Raissa Escandiusi Avramidis, Angélica Mércia Pascon Barbosa, Guilherme Thomaz de Aquino Nava, Danielle Hikaru Nagami, Caroline Baldini Prudencio, Cristiane Rodrigues Pedroni
Journal: PLOS ONE
Accepted: 2022-09-28T00:00:00Z

Introduction: Urgency urinary incontinence (UUI) is characterized by involuntary urine leakage immediately after reporting of sudden, compelling desire to void. Electrostimulation and non-invasive neuromodulation have been considered as the first and third line of UUI treatment but there is a lack of consensus on which parameters are more efficient. Thus, this study aims to compare the effect of low versus medium frequency currents on urinary incontinence severity and quality of life in women with UUI complains. Methods: It will be a randomized controlled trial with 5 arms, double-blinded (outcome assessor and statistician). The study was approved by the Research Ethics Committee (CAAE: 11479119.9.0000.5406) and has been prospectively registered on the Brazilian Registry of Clinical Trials (RBR-8bkkp6). Concerning, double-blind process, the blinded assessor will be responsible for evaluate primary and secondary outcomes at baseline and follow-up without information about allocation and the statistician will perform analyses without information about group codification. One hundred and five participants will be randomized to receive: (1) Transcutaneous tibial nerve stimulation-low frequency, (2) Transcutaneous tibial nerve stimulation-high frequency, (3) Aussie median frequency, (4) Interferencial median frequency or (5) High voltage stimulation. The application will be performed during 20 sessions of 45-minutes, twice a week for 10 weeks, in groups of maximum 5 participants. The participants will be evaluated before treatment (baseline- 0 week), during the treatment (5 weeks) and after the last treatment session (10 weeks). The primary outcomes measures will be UI severity and quality of life, and the secondary outcome will be pelvic floor strength. Statistical analysis will be performed using SPSS software version 24.0 for Windows (IBM Corp., Armonk, N.Y., USA). The variables will be described by the mean and 95% confidence interval. The distribution of normality will be analyzed by the Shapiro-Wilk test. ANOVA for repeated measures will be performed. Mauchly’s test the hypothesis of sphericity and when if this violated the hypotheses, the analyses will be based on the Greenhouse-Geisser test. Peer-to-peer comparisons will be performed using the Bonferroni Post-Hoc test. The significant level adopted will be 5% (p ≤ 0.05). Conclusion: This study will enhance knowledge about effect of different neuromodulation currents in the improvement of UUI.
A product-driven system with an evolutionary algorithm to increase flexibility in planning a job shop
Authors: Patricio Sáez, Carlos Herrera, Camila Booth, Sana Belmokhtar-Berraf, Victor Parada
Journal: PLOS ONE
Accepted: 2023-02-01T00:00:00Z


The scheduling of a job shop production system occurs using models to plan operations for a given period while minimizing the makespan. However, since the resulting mathematical models are computationally demanding, their implementation in the work environment is impractical, a difficulty that increases as the scale problem grows. An alternative approach is to address the problem in a decentralized manner, such that real-time product flow information feeds the control system to minimize the makespan dynamically. Under the decentralized approach, we use a holonic and multiagent systems to represent a product-driven job shop system that allows us to simulate real-world scenarios. However, the computational performance of such systems to control the process in real-time and for different problem scales is unclear. This paper presents a product-driven job shop system model that includes an evolutionary algorithm to minimize the makespan. A multiagent system simulates the model and produces comparative results for different problem scales with classical models. One hundred two job shop problem instances classified as small, medium, and large scale are evaluated. The results suggest that a product-driven system produces near-optimal solutions in short periods and improves its performance as the scale of the problem increases. Furthermore, the computational performance observed during the experimentation suggests that such a system can be embedded in a real-time control process.